Gilead Sciences Insider Trades

GILD

Gilead Sciences (GILD) is a leading biopharmaceutical company based in Foster City, California, dedicated to discovering, developing, and commercializing innovative medicines for life-threatening diseases, including HIV/AIDS, liver diseases, cancer, and inflammatory conditions. The company's leadership includes Chairman and CEO Daniel O'Day, alongside key executives such as Andrew Dickinson (CFO), Flavius Martin (EVP, Research), Johanna Mercier (Chief Commercial Officer), and Merdad Parsey (Chief Medical Officer). The Board of Directors also features prominent individuals like Jacqueline K. Barton and Anthony Welters. Regarding insider trading, activity at Gilead Sciences generally indicates a pattern of more insider selling than buying over recent periods. Executives and directors have engaged in sales of company stock.

Trades Last 12 Months

GILD Price

All Insider Trades for Gilead Sciences

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
O'day Daniel Patrick Chairman & CEO
Holding Value $80.2M 621,667 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.97M 15,000 shares
$131.45
$128.99
Dickinson Andrew D Chief Financial Officer
Holding Value $22.3M 173,191 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$397k 3,000 shares
$132.27
$128.99
Mercier Johanna Chief Comm & Corp Aff Officer
Holding Value $2.98M 23,110 shares
Last Trade
May 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.24M 25,000 shares
$129.58
$128.99
Rodriguez Javier Director
Holding Value $1.72M 13,364 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,030 shares
$130.84
$128.99
Love Ted W Director
Holding Value $707k 5,484 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 1,146 shares
$130.84
$128.99
Horning Sandra Director
Holding Value $812k 6,293 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,030 shares
$130.84
$128.99
Welters Anthony Director
Holding Value $1.66M 12,894 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 1,146 shares
$130.84
$128.99
Kramer Kelly A. Director
Holding Value $2.61M 20,256 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,030 shares
$130.84
$128.99
Manwani Harish Director
Holding Value $630k 4,884 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639k 4,884 shares
$130.84
$128.99
Holding Value $3.51M 27,202 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 1,146 shares
$130.84
$128.99
Holding Value $1.3M 10,066 shares
Last Trade
Apr 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,030 shares
$130.84
$128.99
O'day Daniel Patrick Chairman & CEO
Holding Value $82M 635,617 shares
Last Trade
Apr 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$895k 6,950 shares
$128.79
$128.99
Burkhart Erin Svp, Controllership
Holding Value $1.45M 11,245 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.16M 7,810 shares
$148.56
$128.99
Berger Dietmar Chief Medical Officer
Holding Value $5.04M 39,046 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$317k 2,133 shares
$148.56
$128.99
Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp
Holding Value $2.66M 20,586 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.56M 23,935 shares
$148.56
$128.99
Telman Deborah H Evp, Corporate Affairs & GC
Holding Value $10.3M 79,641 shares
Last Trade
Nov 12, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.62M 53,646 shares
$123.40
$128.99
Wilfong Diane E. Interim Corp Controller & CAO
Holding Value $1.01M 7,864 shares
Last Trade
Sep 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$106k 921 shares
$115.25
$128.99
Patterson Sandra Svp, Controllership
Holding Value $1.27M 9,875 shares
Last Trade
Mar 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$229k 1,952 shares
$117.21
$128.99
Parsey Merdad Chief Medical Officer
Holding Value $10.9M 84,621 shares
Last Trade
Dec 10, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$353k 3,820 shares
$92.34
$128.99
Lofton Kevin E Director
Holding Value $420k 3,258 shares
Last Trade
Mar 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.42k 33 shares
$73.25
$128.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up